معرفی
Joseph F. Levy, PhD, is an Assistant Professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. He is affiliated with the Center for Health Services and Outcomes Research (CHSOR), the Center for Drug Safety and Effectiveness, and the Hopkins Economics of Alzheimer’s Disease & Services Center, reflecting his interdisciplinary engagement in health economics and policy research.
- PhD, University of Wisconsin, 2018
- BS, University of Wisconsin, 2010
Levy’s research centers on health economics, with a focus on cost-effectiveness analysis, drug pricing, orthopedic trauma outcomes, and value-based healthcare decision-making. His work bridges methodological rigor with real-world policy implications, particularly in pharmaceutical economics and healthcare financing. He investigates how economic evaluations can inform equitable and efficient healthcare delivery, especially in trauma care, cancer therapy, and chronic disease management.
His recent publications span high-impact journals such as JAMA, Value in Health, and Health Affairs, covering topics including biosimilar market dynamics, Medicare coverage expansion, and economic impacts of trauma. The body of his work demonstrates a consistent trend toward evaluating healthcare interventions through economic modeling and policy analysis, with increasing attention to equity and patient-centered outcomes.
Levy has no listed scientific awards in the provided materials.
He is actively involved in teaching, including the course Economic Evaluation II, and collaborates with large multidisciplinary research teams, such as the Major Extremity Trauma Research Consortium (METRC). While no formal advisees are listed, his leadership in research projects suggests mentorship roles. He has contributed to significant studies on healthcare costs, drug safety, and health system performance during crises like the pandemic.
Levy is part of active research networks focused on health services and outcomes, with collaborations spanning public health, clinical medicine, and policy institutions. His recent work includes exploring equity in healthcare procurement and the economic burden of chronic conditions.
